Ranzato, Federica
Roberti, Roberta
Deluca, Cristina
Carta, Mariarosa
Peretti, Alessia
Polo, Diana
Perini, Francesco
Russo, Emilio http://orcid.org/0000-0002-1279-8123
Di Gennaro, Gianfranco
Funding for this research was provided by:
Università degli studi "Magna Graecia" di Catanzaro
Article History
Received: 22 May 2023
Accepted: 29 July 2023
First Online: 7 August 2023
Declarations
:
: The study was approved by local ethic committee of Vicenza Hospital in October 28, 2022; n° 1783 and conducted in accordance with the Declaration of Helsinki.
: ER has received speaker fees or funding from, and has participated in advisory boards for, Arvelle Therapeutics, Angelini Pharma, Eisai, Pfizer, GW Pharmaceuticals, JAZZ pharmaceuticals, UCB, and Lundbeck; FR has received speaker fees from Angelini Pharma, Eisai, UCB, and LivaNova and has participated in advisory board for Angelini Pharma; MC has received speaker fees from IL Werfen, Bedford, MA, USA. All other authors report no conflicts of interest.